Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.

Source:http://linkedlifedata.com/resource/pubmed/id/6361173

Download in:

View as

General Info

PMID
6361173